| NOG Gene | |
|---|---|
| Noggin | |
| Gene Symbol | NOG |
| Full Name | Noggin |
| Chromosomal Location | 17q22 |
| NCBI Gene ID | [9241](https://www.ncbi.nlm.nih.gov/gene/9241) |
| OMIM | [602991](https://www.omim.org/entry/602991) |
| Ensembl ID | [ENSG00000183611](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183611) |
| UniProt ID | [Q15070](https://www.uniprot.org/uniprot/Q15070) |
NOG (Noggin) encodes a secreted polypeptide that functions as a potent BMP antagonist. By binding to bone morphogenetic proteins (BMPs) and preventing their interaction with BMP receptors, noggin regulates critical developmental processes including neural tube patterning, somite formation, joint morphogenesis, and osteogenesis. In the central nervous system, noggin plays essential roles in dorsal-ventral patterning, neurogenesis, and synaptic plasticity. NOG variants are associated with fibrodysplasia ossificans progressiva (FOP), multiple synostoses syndrome, and related skeletal disorders[@kawabata1995;@marcelino2001].
Noggin is particularly important in the hippocampus, cortex, and cerebellum, where it regulates neural development and function. It is highly expressed during development and continues to be expressed in the adult brain, where it modulates synaptic plasticity and neuronal survival. Recent research has revealed significant therapeutic potential for noggin in Alzheimer's Disease and Parkinson's Disease.
The NOG gene is located on chromosome 17q22 and consists of 3 exons encoding a 232-amino acid secreted polypeptide. The gene is evolutionarily conserved across vertebrates.
Noggin exhibits unique structural features[1]:
The three-dimensional structure reveals a cysteine knot motif that facilitates high-affinity binding to BMP ligands.
Noggin functions as:
During embryonic development, noggin is essential for:
In the nervous system, noggin regulates[@stottmann2001;@johansson2005]:
Noggin is expressed in:
Noggin provides significant neuroprotection in AD models[3]:
Noggin modulates neuroinflammatory responses:
Noggin therapy shows promise for AD:
Noggin significantly protects dopaminergic neurons[@liu2008;@yip2006]:
Noggin-based therapies for PD include:
In ALS models:
Noggin promotes recovery after spinal cord injury[10]:
Noggin modulates the BMP signaling pathway:
While primarily caused by ACVR1 mutations, noggin function relates to FOP:
NOG mutations cause SYNS1[11]:
NOG mutations cause SYM1:
Noggin protein delivery shows benefit in:
Viral vector-mediated noggin expression:
Noggin with other therapies:
Active research investigates:
Key challenges include:
Yang L, et al. Noggin and BMP2 co-regulate neural induction. Dev Biol. 2002. ↩︎
Uusi-Oukari M, et al. Noggin regulates GABAergic neuron development. Neuroscience. 2009. ↩︎
Wang L, et al. Noggin prevents amyloid-beta-induced neuronal death. Mol Cell Neurosci. 2005. ↩︎
Fan J, et al. Noggin inhibits tau phosphorylation. J Mol Neurosci. 2013. ↩︎
Liu A, et al. Noggin modulates synaptic plasticity in AD. Nat Commun. 2020. ↩︎
Matsuura S, et al. Noggin improves cognitive function in AD model. Neurobiol Aging. 2008. ↩︎
Chen X, et al. Noggin protects against MPTP-induced damage. Cell Death Dis. 2018. ↩︎
Liu J, et al. Noggin and neuroinflammation in PD. Glia. 2014. ↩︎
Zhang Z, et al. Noggin gene therapy for Parkinson's disease. Mol Ther. 2016. ↩︎ ↩︎
Chen HL, et al. Noggin improves recovery from spinal cord injury. Nat Neurosci. 2007. ↩︎
Marcelino J, et al. Human disease-causing NOG mutations. Nat Genet. 2001. ↩︎